Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer-Reference-Cited by-同舟云学术

Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer

Published:2023-09 Issue:9 Volume:4 Page:101162
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Li Yunguang,Tang Shijie,Shi Xiaohan,Lv Jingwen,Wu Xueyuan,Zhang Yehan,Wang Huan,He Juan,Zhu Yiqin,Ju Yi,Zhang Yajuan,Guo Shiwei,Yang Weiwei,Yin Huiyong,Chen Luonan,Gao Dong,Jin Gang

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference86 articles.

1. Cancer statistics, 2022;Siegel;CA A Cancer J. Clin.,2022

2. Chemoresistance in Pancreatic Cancer;Zeng;Int. J. Mol. Sci.,2019

3. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N. Engl. J. Med.,2011

4. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N. Engl. J. Med.,2013

5. Molecular subtypes of pancreatic cancer;Collisson;Nat. Rev. Gastroenterol. Hepatol.,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond glucose and Warburg: finding the sweet spot in cancer metabolism models;npj Metabolic Health and Disease;2024-09-02

2. Emerging mechanisms and promising approaches in pancreatic cancer metabolism;Cell Death & Disease;2024-08-01

3. Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer;Molecular Cancer;2024-07-09

4. The Cancer Antioxidant Regulation System in Therapeutic Resistance;Antioxidants;2024-06-27

5. Deciphering fatty acid biosynthesis-driven molecular subtypes in pancreatic ductal adenocarcinoma with prognostic insights;Cellular Oncology;2024-05-16